Achieve Life Sciences
ACHV
ACHV
28 hedge funds and large institutions have $7M invested in Achieve Life Sciences in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $9.97M → $7M (-$2.97M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
28
Holding in Top 10
–
Calls
$195K
Puts
$69K
Top Buyers
| 1 | +$431K | |
| 2 | +$79.9K | |
| 3 | +$72K | |
| 4 |
Jane Street
New York
|
+$53K |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$49.8K |
Top Sellers
| 1 | -$184K | |
| 2 | -$115K | |
| 3 | -$104K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$54.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.1K |